How Much Does Cialis (Tadalafil) Cost in Indiana in 2026?

Brand vs. Generic vs. Compounded: Three Price Tiers

Indiana men filling a tadalafil prescription in 2026 face three distinct price bands, and the spread between them is wide. Brand-name Cialis from Eli Lilly lists near $450 for a 30-day supply. Generic tadalafil, available since Cialis lost patent exclusivity in 2018, averages about $80 per month at Indiana retail chains like CVS, Walgreens, and Kroger Pharmacy. Compounded tadalafil from a state-licensed 503A compounding pharmacy brings the cost down to approximately $40 per month.

The brand-to-generic gap exists because Eli Lilly no longer holds market exclusivity, and multiple manufacturers (Teva, Cipla, Lupin, Aurobindo, among others) now produce FDA-rated generic equivalents. The FDA Orange Book confirms AB-rated bioequivalent generics across all tadalafil dosage strengths: 2.5 mg, 5 mg, 10 mg, and 20 mg tablets. Bioequivalence means identical active ingredient, dose form, route of administration, and pharmacokinetic profile within the 80% to 125% confidence interval required by FDA guidance [1].

Compounded tadalafil sits at the lowest price tier. Under federal law (section 503A of the FD&C Act), a licensed compounding pharmacy can prepare tadalafil for an individual patient with a valid prescription. Indiana does not impose additional state-level restrictions beyond standard Board of Pharmacy compounding rules. The savings come from lower overhead: compounders purchase bulk tadalafil powder (an API, or active pharmaceutical ingredient) and formulate it on-site rather than running large-scale manufacturing and distribution operations.

One caution. Compounded products are not FDA-approved finished dosage forms and do not undergo the same batch-level testing as manufactured generics. The FDA has stated that patients should understand this distinction before choosing a compounded product.

Indiana Medicaid: What Is and Is Not Covered

Indiana Medicaid does not cover tadalafil for erectile dysfunction. This is consistent with federal Medicaid rules that have excluded ED drugs from mandatory coverage since the Deficit Reduction Act of 2005. However, tadalafil carries a second FDA-approved indication: daily 5 mg dosing for benign prostatic hyperplasia (BPH), marketed under the brand name Cialis. Indiana Medicaid may cover tadalafil 5 mg daily when prescribed specifically for BPH with appropriate documentation, though prior authorization is typically required.

Men with type 2 diabetes and concurrent ED may find a limited pathway. Some Indiana Managed Care Entities (MCEs) have carved out exceptions when the prescriber documents a medical necessity argument tying erectile dysfunction to diabetic neuropathy as a complication of the covered condition. This is not guaranteed. Each MCE (Anthem, MDwise, MHS, CareSource) adjudicates these requests independently.

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy in men with hypogonadism notes that PDE5 inhibitors such as tadalafil are first-line pharmacotherapy for ED regardless of testosterone status [2]. This guideline does not override payer policy, but it provides clinical grounding for appeals.

For Hoosier Healthwise (Indiana's CHIP program) and the Healthy Indiana Plan (HIP 2.0), tadalafil for ED is similarly excluded. Members on these plans who need ED treatment should discuss alternatives with their prescriber, including manufacturer savings programs or cash-pay generic pricing that may be less expensive than a formulary appeal.

Private Insurance Coverage in Indiana

Commercial plans in Indiana vary widely. Large employer-sponsored plans from Anthem Blue Cross Blue Shield, UnitedHealthcare, Cigna, and Aetna often place generic tadalafil on Tier 2 or Tier 3 of their formularies. Copays range from $15 to $75 per fill depending on the plan design, quantity limits, and whether step therapy or prior authorization applies.

Quantity limits are common. Many Indiana commercial plans cap tadalafil at 6 to 12 tablets per month for on-demand dosing (10 mg or 20 mg), which translates to roughly two to three uses per week. Daily dosing (2.5 mg or 5 mg, 30 tablets per month) is sometimes covered without quantity limits when prescribed for BPH or BPH-plus-ED.

Self-insured employer plans, which cover the majority of commercially insured workers in Indiana, set their own formulary rules. A 2023 Kaiser Family Foundation survey found that 26% of large employer plans excluded ED drugs entirely [3]. If your plan excludes tadalafil, the cash-pay generic price ($80/month) or compounded price ($40/month) becomes the relevant benchmark.

One strategy: ask the prescriber to write the prescription for "tadalafil 5 mg daily for BPH/LUTS" when the patient has documented lower urinary tract symptoms. The FDA-approved label for Cialis includes both BPH and ED as approved indications, and payers are more likely to cover the BPH indication without restrictions [4].

How Telehealth Prescribing Works in Indiana

Indiana permits telehealth prescribing of tadalafil. The state updated its telemedicine statutes (IC 25-1-9.5) to allow synchronous audio-video encounters to establish a prescriber-patient relationship. A physician, nurse practitioner, or physician assistant licensed in Indiana can evaluate the patient, confirm the absence of contraindications (nitrate use, severe hepatic impairment, recent stroke or MI within 90 days), and transmit the prescription electronically to any Indiana pharmacy.

The clinical evaluation for tadalafil is straightforward. The International Index of Erectile Function (IIEF-5), a validated 5-question screening tool, establishes symptom severity [5]. Cardiovascular risk stratification follows the Princeton III Consensus recommendations: low-risk men (able to perform moderate exercise such as climbing two flights of stairs without cardiac symptoms) can safely initiate PDE5 inhibitor therapy without additional cardiac workup [6].

Telehealth platforms operating in Indiana typically offer generic tadalafil bundled with the consultation fee. Prices range from $1 to $3 per tablet for on-demand doses when purchased through these platforms, which often use their own pharmacy fulfillment networks. Compare that to the retail cash-pay benchmark of roughly $2.50 to $3 per tablet at a brick-and-mortar Indiana pharmacy.

Efficacy: What the Trial Data Shows

Tadalafil's efficacy profile is well-established. The key registration trial by Brock et al. (2002) enrolled 1,112 men with ED across multiple sites and randomized them to tadalafil 10 mg, 20 mg, or placebo taken on demand [7]. At 12 weeks, 67% of intercourse attempts were successful with tadalafil 20 mg versus 32% with placebo (P<0.001). The mean improvement in IIEF erectile function domain score was 7.9 points with 20 mg versus 0.6 with placebo.

What distinguishes tadalafil from sildenafil and vardenafil is its 17.5-hour half-life, which supports both on-demand use and continuous daily dosing. The Porst et al. (2006) study confirmed that daily tadalafil 5 mg produced a mean IIEF-EF domain improvement of 6.2 points over 24 weeks, with consistent efficacy across all timepoints measured (no tachyphylaxis) [8]. Dr. Harin Padma-Nathan, who led several of the early tadalafil trials, noted: "The prolonged half-life of tadalafil allows couples to separate the act of taking a pill from the act of intercourse, which addresses one of the most common complaints about on-demand PDE5 inhibitors."

For the BPH indication, the CombAT study and subsequent Eli Lilly trials showed that tadalafil 5 mg daily reduced International Prostate Symptom Score (IPSS) by 4.8 points versus 2.2 for placebo at 12 weeks [9]. This magnitude of symptom improvement is clinically meaningful and comparable to alpha-blocker monotherapy for mild-to-moderate LUTS.

Discount Programs and Savings Cards

Several discount mechanisms can reduce tadalafil costs for Indiana residents.

GoodRx, RxSaver, and similar aggregators. These platforms negotiate contracted rates with pharmacy benefit managers and display real-time pricing at Indiana pharmacies. Generic tadalafil 5 mg (30 tablets) through these coupons often prices between $15 and $40, well below the $80 average retail cash price. Prices fluctuate weekly and vary by pharmacy location within Indiana.

Eli Lilly Cialis Savings Card. Lilly offers a manufacturer savings card for brand-name Cialis that reduces patient out-of-pocket cost to as low as $25 per prescription for commercially insured patients. The card is not valid for patients on government insurance (Medicare, Medicaid, Tricare, VA). Given that generic tadalafil is available at $15 to $40 with discount coupons, the savings card's value is limited to patients whose insurance covers brand Cialis with a high copay.

Mark Cuban Cost Plus Drugs (costplusdrugs.com). This direct-to-consumer pharmacy sells generic tadalafil at a transparent markup (manufacturer cost plus 15% plus a flat dispensing fee). Tadalafil 5 mg, 30 tablets, is listed at approximately $5 to $8 through this channel, with mail-order delivery to Indiana addresses. This is currently one of the lowest per-unit prices available.

VA and Military. Indiana veterans enrolled in VA healthcare can obtain tadalafil through the VA formulary at no copay or minimal copay ($5 to $11 per 30-day supply depending on priority group).

Decision framework for choosing a cost pathway: Pick brand Cialis only if your insurer covers it at a copay below $30. Choose generic tadalafil at a retail pharmacy with a discount coupon if you prefer brick-and-mortar pickup and the price falls under $40. Choose a mail-order pharmacy (Cost Plus, telehealth platform fulfillment) if you prioritize lowest unit cost. Choose compounded tadalafil only if you need a non-standard dose or formulation (sublingual troche, combination product) that manufactured generics do not offer.

Compounded Tadalafil in Indiana: Legality and Access

Compounded tadalafil is legal in Indiana when dispensed by a 503A-licensed pharmacy pursuant to a valid patient-specific prescription. Indiana Board of Pharmacy regulations (856 IAC 1-35) govern compounding practices and align with USP chapters 795 (nonsterile compounding) and 797 (sterile compounding, when applicable).

A 503A pharmacy compounds medications for individual patients. This is distinct from 503B outsourcing facilities, which can compound without patient-specific prescriptions and distribute to healthcare facilities. Both pathways are available in Indiana, but for individual retail patients, the 503A route is standard.

Common compounded tadalafil formulations include sublingual troches (rapid absorption, bypasses first-pass metabolism), combination troches with oxytocin or PT-141, and custom-dose capsules for patients who need strengths not commercially available (e.g., 7.5 mg or 15 mg). Pricing at Indiana 503A pharmacies ranges from $30 to $60 per month depending on formulation complexity.

The FDA's 2023 guidance on compounding clarifies that compounders may prepare copies of commercially available drugs when they can document a clinical difference (different dose, different route, different inactive ingredient to avoid an allergy). Simply compounding tadalafil 5 mg tablets identical to the commercial product to undercut pricing is technically outside the intent of 503A, though enforcement in practice focuses on safety rather than price competition [10].

Safety Profile and Contraindications

Tadalafil's safety profile is documented across more than two decades of post-marketing surveillance. The most common adverse effects in clinical trials were headache (15%), dyspepsia (10%), back pain (6%), myalgia (5%), nasal congestion (3%), and flushing (3%) [4]. These are dose-dependent and generally mild.

Absolute contraindications are narrow but critical. Tadalafil must not be combined with nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite) due to risk of severe, potentially fatal hypotension. The ACC/AHA guidelines recommend a minimum 48-hour washout between tadalafil and any nitrate administration, longer than the 24-hour window for sildenafil, because of tadalafil's extended half-life [11].

Alpha-blockers (tamsulosin, doxazosin) require caution. The FDA label recommends that patients be stable on alpha-blocker therapy before adding tadalafil, and that tadalafil be initiated at the lowest dose (2.5 mg daily or 5 mg on-demand) to minimize orthostatic hypotension risk. In Indiana, where many men over 50 take tamsulosin for BPH, prescribers should verify the medication list before writing the tadalafil prescription.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a principal investigator in multiple PDE5 inhibitor trials, has stated: "PDE5 inhibitors as a class have an excellent safety record spanning over 25 years. The contraindication with nitrates is absolute, but for men who are not on nitrates and have been cleared for sexual activity, these drugs are remarkably well-tolerated."

What to Tell Your Indiana Prescriber

Before your appointment (whether in-person or telehealth), prepare a current medication list with attention to nitrates, alpha-blockers, and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin), which can increase tadalafil blood levels. Know your blood pressure. If you have had a cardiovascular event in the past six months, bring records. The prescriber needs this information to determine starting dose: 2.5 mg daily for continuous use, 10 mg on-demand as the initial dose, with titration to 5 mg daily or 20 mg on-demand based on efficacy and tolerability [4].

For men with both ED and LUTS/BPH, tadalafil 5 mg daily is the only PDE5 inhibitor FDA-approved to treat both conditions simultaneously. This single-pill approach can replace a separate alpha-blocker in selected patients, simplifying the regimen and potentially improving insurance coverage since the BPH indication faces fewer formulary restrictions in Indiana commercial plans.